Labcorp Enters Material Agreement, Incurs Financial Obligation

TL;DR

Labcorp just signed a big deal and took on debt. Details TBD.

AI Summary

On June 27, 2025, LABCORP HOLDINGS INC. entered into a material definitive agreement and incurred a direct financial obligation. The filing does not specify the counterparty or the exact nature of the agreement or obligation, but it is classified as a current report under the Securities Exchange Act of 1934.

Why It Matters

This filing indicates a significant new financial commitment or partnership for Labcorp, which could impact its future financial performance and strategic direction.

Risk Assessment

Risk Level: medium — The filing indicates a material definitive agreement and a direct financial obligation, suggesting a significant event that could carry financial risks or opportunities.

Key Players & Entities

• LABCORP HOLDINGS INC. (company) — Registrant
• June 27, 2025 (date) — Date of earliest event reported
• 358 South Main Street (address) — Business Address
• Burlington (city) — Business Address City
• North Carolina (state) — Business Address State
• 27215 (zip_code) — Business Address Zip

FAQ

From the Filing

0001193125-25-151281.txt : 20250627 0001193125-25-151281.hdr.sgml : 20250627 20250627161625 ACCESSION NUMBER: 0001193125-25-151281 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250627 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250627 DATE AS OF CHANGE: 20250627 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LABCORP HOLDINGS INC. CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 992588107 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 251086542 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS DATE OF NAME CHANGE: 19950504 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 8-K 1 d84939d8k.htm 8-K 8-K false 0000920148 0000920148 2025-06-27 2025-06-27     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549     FORM 8-K     CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 June 27, 2025 (Date of earliest event reported)     LABCORP HOLDINGS INC. (Exact name of Registrant as Specified in its Charter)       Delaware   1-11353   99-2588107 (State or other jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)   358 South Main Street   Burlington ,   North Carolina   27215 (Address of principal executive offices)   (Zip Code) (Registrant’s telephone number, including area code) (336) 229-1127     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, $0.10 par value   LH   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 1.01. Entry into a Material Definitive Agreement On June 27, 2025 (the “Closing Date”), Labcorp Holdings Inc. (the “Company”), as parent guarantor, and Laboratory Corporation of America Holdings (“LCAH”), as borrower, entered into a Fourth Amended and Restated Credit Agreement (the “Credit Agreement”) with Bank of America